HUMAN PHARMACOLOGY OF NARCOTIC-ANTAGONISTS

被引:41
作者
JASINSKI, DR
机构
关键词
D O I
10.1111/j.1365-2125.1979.tb04702.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Human studies at the Addiction Research Center enable narcotic antagonists to be classified into three subgroups: (1) nalorphine‐like agents; (2) pure antagonists; and (3) morphine‐like agents. 2 Six narcotic antagonists (pentazocine, nalbuphine, cyclazocine, butorphanol, propiram and buprenorphine) developed in recent years seem to have a lesser abuse potential than codeine or propoxyphene. 3 When adjusted for relative availability of the agents, epidemiological data shows that pentazocine is abused less than codeine or propoxyphene in the US. 4 Recent studies with buprenorphine indicate that this agent would find application both as an analgesic of low abuse potential and as a new type of drug for the treatment of addiction. 1979 The British Pharmacological Society
引用
收藏
页码:S287 / S290
页数:4
相关论文
共 12 条
[1]  
FRASER HF, 1964, J PHARMACOL EXP THER, V143, P149
[2]  
JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501
[3]  
JASINSKI DR, 1970, CLIN PHARMACOL THER, V11, P385
[4]  
JASINSKI DR, 1975, 37TH M COMM PROBL DR
[5]  
JASINSKI DR, 1977, DRUG ADDICTION I MOR, V45, P197
[6]  
JASINSKI DR, 1977, 39TH M COMM PROBL DR
[7]  
JASINSKI DR, 1976, 38TH M COMM PROBL DR
[8]  
JASINSKI JR, 1972, CLIN PHARMACOL THER, V13, P78
[9]  
MARTIN WR, 1965, J PHARMACOL EXP THER, V150, P437
[10]  
MARTIN WR, 1971, CLIN PHARMACOL THER, V12, P245